Ashley Allen
Physician Assistant · Reno, NVNPI 1194324574
Payments from drug & device makers
Across 203 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$1K
- AbbVie$800
- Boehringer Ingelheim$494
- Novo Nordisk$376
- Pfizer$257
- plus $1K from 17 others
What the payments were for
- Food & beverage$5,15798%
- Education$952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 37 | $1,065 |
| AstraZeneca | 41 | $1,051 |
| AbbVie | 47 | $800 |
| Boehringer Ingelheim | 16 | $494 |
| Novo Nordisk | 5 | $376 |
| Pfizer | 10 | $257 |
| Lilly USA, LLC | 7 | $240 |
| Sanofi-aventis U.S. LLC | 9 | $209 |
| Bayer | 7 | $162 |
| Astellas Pharma US Inc | 1 | $95 |
| Amgen | 4 | $91 |
| Exact Sciences | 3 | $74 |
| Novartis | 2 | $51 |
| Idorsia Pharmaceuticals US Inc | 2 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Redhill Biopharma Inc. | 1 | $24 |
| Vertex | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,252 in reported general payments places this provider in the 85th percentile of 881 physician assistant providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $25,843 |
| EliquisApixaban | 13 | $19,992 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $13,002 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,419 |
| Atorvastatin Calcium | 71 | $1,812 |
| Rosuvastatin Calcium | 25 | $1,157 |
| Levothyroxine Sodium | 59 | $852 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $820 |
| Tamsulosin Hcl | 18 | $583 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $523 |
| Pantoprazole Sodium | 13 | $482 |
| Gabapentin | 15 | $455 |
| Trazodone Hcl | 30 | $452 |
| Metformin Hcl | 38 | $411 |
| RizatriptanRizatriptan Benzoate | 13 | $373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $376 | $25,84311 claims |
| PfizerEliquis | $257 | $19,99213 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,065 | $18,42223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 881 physician assistant providers in Nevada.
Other physician assistant in Reno
- John LarsenReno$49K
- Laura BiehleReno$36K
- Benjamin ProhaskaReno$31K
- Rebecca SparksReno$16K
- Daniel CollReno$12K
- Cameron WheelerReno$11K
- Julia WronaReno$10K
- Amber FrancoReno$9K
- Paul JohnsReno$8K
- Shannon WeaverReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.